MEIP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

MEI Pharma Insider Trading History Chart

MEI Pharma Share Price & Price History

^$3.07

▼ -0.03 (-0.97%)

As of 11/1/2024 01:00 AM ET

Days: 30 | 90 | 365

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

MEI Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/22/2023	Anson Funds Management Lp	Major Shareholder	Buy	48,060	$6.85	$329,211.00	864,188
9/20/2023	Anson Funds Management Lp	Major Shareholder	Buy	120,000	$6.01	$721,200.00	782,528
2/28/2023	Charles V Baltic III	Director	Buy	4,075	$4.60	$18,745.00	5,287

Why Buffett, Bezos, & Congress Are Piling Into This One Sector

From InvestorPlace | Ad

Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…

Click here for the details

SEC Filings (Institutional Ownership Changes) for MEI Pharma (NASDAQ:MEIP)

52.38% of MEI Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

MEI Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/6/2024	Acadian Asset Management LLC	150,150	$0.44M	0.0%	-29.1%	2.255%
8/3/2024	National Bank of Canada FI	33,000	$94K	0.0%	+43.5%	0.495%
5/14/2024	Carlson Capital L P	64,000	$0.26M	0.0%	-13.5%	0.961%
5/10/2024	Acadian Asset Management LLC	211,733	$0.85M	0.0%	-6.1%	3.178%
2/20/2024	Cable Car Capital LLC	611,440	$3.55M	3.9%	N/A	9.181%
2/6/2024	National Bank of Canada FI	6,000	$36K	0.0%	N/A	0.090%
8/15/2023	Boxer Capital LLC	145,654	$0.96M	0.0%	-95.0%	2.187%
8/14/2023	Anson Funds Management LP	662,528	$4.36M	0.7%	-95.0%	9.948%
8/10/2023	Carlson Capital L P	135,000	$0.89M	0.1%	-93.6%	2.027%
8/7/2023	Acadian Asset Management LLC	230,545	$1.52M	0.0%	-95.2%	3.462%
8/4/2023	Simplex Trading LLC	4,326	$28K	0.0%	N/A	0.065%
7/24/2023	BML Capital Management LLC	22,966	$0.15M	0.1%	N/A	0.345%
5/19/2023	Anson Funds Management LP	13,250,582	$3.03M	0.5%	+24.8%	198.958%
11/15/2022	Carlson Capital L P	1,150,000	$0.45M	0.0%	+4.5%	0.863%
11/14/2022	Annandale Capital LLC	100,000	$39K	0.0%	N/A	0.075%
11/14/2022	Zacks Investment Management	109,819	$42K	0.0%	N/A	0.082%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	190,305	$74K	0.0%	+148.7%	0.143%
11/4/2022	Prudential Financial Inc.	77,200	$30K	0.0%	N/A	0.058%
10/27/2022	Assenagon Asset Management S.A.	101,901	$39K	0.0%	N/A	0.076%
8/15/2022	Laurion Capital Management LP	2,576,900	$1.56M	0.0%	N/A	1.938%
8/11/2022	Sigma Planning Corp	632,200	$0.38M	0.0%	+50.9%	0.475%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	76,514	$46K	0.0%	N/A	0.058%
5/12/2022	Anson Funds Management LP	3,449,809	$2.08M	0.2%	+23.4%	2.594%
5/11/2022	GSA Capital Partners LLP	60,923	$37K	0.0%	+111.0%	0.046%
4/25/2022	Assenagon Asset Management S.A.	184,003	$0.11M	0.0%	+1,298.4%	0.138%
4/20/2022	Sigma Planning Corp	418,950	$0.25M	0.0%	+164.6%	0.315%
2/19/2022	Woodline Partners LP	1,508,520	$4.03M	0.1%	+1.4%	1.134%
2/16/2022	Wasatch Advisors Inc.	9,342,310	$24.94M	0.1%	+47.4%	7.025%
2/14/2022	Opaleye Management Inc.	1,315,000	$3.51M	0.7%	-16.0%	1.167%
2/14/2022	Point72 Asset Management L.P.	2,800,500	$7.48M	0.0%	+155.9%	2.484%
2/14/2022	DAFNA Capital Management LLC	1,764,846	$4.71M	1.2%	+175.3%	1.566%
2/14/2022	GSA Capital Partners LLP	28,873	$77K	0.0%	-47.6%	0.026%
2/11/2022	Eagle Asset Management Inc.	11,387	$30K	0.0%	N/A	0.010%
2/11/2022	Bioimpact Capital LLC	12,350,971	$32.98M	6.0%	N/A	10.957%
2/10/2022	Panagora Asset Management Inc.	107,052	$0.29M	0.0%	-62.4%	0.095%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	119,674	$0.32M	0.0%	-45.2%	0.106%
2/9/2022	Lazard Asset Management LLC	18,848	$50K	0.0%	N/A	0.017%
2/9/2022	Alps Advisors Inc.	150,655	$0.40M	0.0%	+9.1%	0.134%
2/8/2022	Raymond James & Associates	17,413	$46K	0.0%	-41.8%	0.015%
2/8/2022	ProShare Advisors LLC	23,688	$63K	0.0%	+70.5%	0.021%
2/8/2022	Northern Trust Corp	990,614	$2.65M	0.0%	-4.9%	0.879%
2/7/2022	SG Americas Securities LLC	14,830	$40K	0.0%	-61.5%	0.013%
2/3/2022	Los Angeles Capital Management LLC	17,164	$46K	0.0%	-53.9%	0.015%
2/2/2022	Sigma Planning Corp	158,350	$0.42M	0.0%	+9.7%	0.140%
2/1/2022	Assenagon Asset Management S.A.	13,158	$35K	0.0%	-56.4%	0.012%
1/28/2022	Allspring Global Investments Holdings LLC	116,833	$0.31M	0.0%	N/A	0.104%
11/17/2021	Strategic Wealth Advisors Group LLC	165,500	$0.46M	0.0%	+5.4%	0.147%
11/16/2021	Squarepoint Ops LLC	88,389	$0.24M	0.0%	-13.3%	0.078%
11/16/2021	Two Sigma Advisers LP	297,104	$0.82M	0.0%	-35.8%	0.264%
11/16/2021	Metropolitan Life Insurance Co NY	17,182	$47K	0.0%	-34.6%	0.015%
11/15/2021	Point72 Asset Management L.P.	1,094,367	$3.02M	0.0%	+1.0%	0.971%
11/15/2021	Man Group plc	12,300	$34K	0.0%	N/A	0.011%
11/15/2021	Virtus ETF Advisers LLC	64,819	$0.18M	0.1%	-5.0%	0.058%
11/15/2021	GSA Capital Partners LLP	55,095	$0.15M	0.0%	+99.0%	0.049%
11/12/2021	Renaissance Technologies LLC	998,773	$2.76M	0.0%	-13.9%	0.886%
11/12/2021	Wasatch Advisors Inc.	6,339,734	$17.50M	0.1%	-4.5%	5.625%
11/12/2021	Geode Capital Management LLC	1,694,637	$4.68M	0.0%	+1.9%	1.504%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	218,366	$0.60M	0.0%	-28.9%	0.194%
11/10/2021	Goldman Sachs Group Inc.	290,201	$0.80M	0.0%	-38.2%	0.257%
11/10/2021	Panagora Asset Management Inc.	284,847	$0.79M	0.0%	-7.6%	0.253%
11/10/2021	Citigroup Inc.	12,979	$36K	0.0%	+151.5%	0.012%
11/10/2021	Alliancebernstein L.P.	72,100	$0.20M	0.0%	-7.1%	0.064%
11/9/2021	Barclays PLC	44,304	$0.12M	0.0%	+205.4%	0.039%
11/9/2021	BlackRock Inc.	6,605,906	$18.23M	0.0%	-3.8%	5.861%
11/9/2021	Principal Financial Group Inc.	22,945	$63K	0.0%	+36.4%	0.020%
11/4/2021	Deutsche Bank AG	66,224	$0.18M	0.0%	-13.1%	0.059%
11/2/2021	New York State Common Retirement Fund	54,531	$0.15M	0.0%	-41.1%	0.048%
11/1/2021	SG Americas Securities LLC	38,543	$0.11M	0.0%	N/A	0.034%
10/28/2021	Sigma Planning Corp	144,350	$0.40M	0.0%	+70.9%	0.128%
10/25/2021	Jaffetilchin Investment Partners LLC	33,000	$91K	0.0%	-50.0%	0.029%
10/19/2021	Assenagon Asset Management S.A.	30,191	$83K	0.0%	-46.7%	0.027%
9/17/2021	Virtu Financial LLC	47,627	$0.14M	0.0%	N/A	0.042%
9/3/2021	Parametric Portfolio Associates LLC	34,192	$97K	0.0%	+71.8%	0.030%
8/17/2021	Woodline Partners LP	2,360,616	$6.73M	0.1%	+270.4%	2.097%
8/17/2021	Metropolitan Life Insurance Co NY	26,253	$75K	0.0%	+163,981.3%	0.023%
8/17/2021	Millennium Management LLC	605,211	$1.73M	0.0%	+50.3%	0.538%
8/17/2021	MetLife Investment Management LLC	11,490	$33K	0.0%	-76.0%	0.010%
8/17/2021	Boothbay Fund Management LLC	82,818	$0.24M	0.0%	+80.2%	0.074%
8/17/2021	BVF Inc. IL	3,532,057	$10.07M	0.4%	-1.6%	3.137%
8/16/2021	Squarepoint Ops LLC	101,993	$0.29M	0.0%	N/A	0.091%
8/16/2021	Amalgamated Bank	20,472	$58K	0.0%	+29.9%	0.018%
8/16/2021	Point72 Asset Management L.P.	1,083,009	$3.09M	0.0%	-5.8%	0.962%
8/16/2021	Opaleye Management Inc.	1,565,000	$4.46M	0.7%	+0.6%	1.390%
8/16/2021	California State Teachers Retirement System	149,520	$0.43M	0.0%	-9.9%	0.133%
8/16/2021	Morgan Stanley	63,616	$0.18M	0.0%	+287.9%	0.057%
8/16/2021	Charles Schwab Investment Management Inc.	775,628	$2.21M	0.0%	-1.2%	0.689%
8/16/2021	State Street Corp	1,871,702	$5.33M	0.0%	+5.7%	1.662%
8/16/2021	Nuveen Asset Management LLC	372,088	$1.06M	0.0%	-6.5%	0.330%
8/16/2021	Goldman Sachs Group Inc.	469,246	$1.34M	0.0%	-42.9%	0.417%
8/13/2021	First Light Asset Management LLC	6,995,707	$19.94M	1.2%	+9.7%	6.213%
8/13/2021	Renaissance Technologies LLC	1,160,073	$3.31M	0.0%	-35.2%	1.030%
8/13/2021	Northern Trust Corp	1,046,724	$2.98M	0.0%	-3.9%	0.930%
8/13/2021	Altium Capital Management LP	1,828,066	$5.21M	1.2%	+186.5%	1.624%
8/13/2021	Natixis	10,000	$30K	0.0%	N/A	0.009%
8/13/2021	Sigma Planning Corp	84,450	$0.24M	0.0%	+6.3%	0.075%
8/13/2021	Geode Capital Management LLC	1,662,676	$4.74M	0.0%	+0.9%	1.477%
8/13/2021	Vanguard Group Inc.	5,253,797	$14.97M	0.0%	-2.0%	4.666%
8/12/2021	Wasatch Advisors Inc.	6,639,160	$18.92M	0.1%	-0.3%	5.897%
8/12/2021	Dimensional Fund Advisors LP	378,463	$1.08M	0.0%	+247.5%	0.336%
8/12/2021	JPMorgan Chase & Co.	98,873	$0.28M	0.0%	+118.9%	0.088%

Data available starting January 2016

MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor for the treatment of patients with relapsed/refractory follicular lymphoma; and Voruciclib, an oral cyclin-dependent kinase 9 inhibitor, which is in Phase I clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex which has completed Phase I clinical trial for the treatment of human epidermal growth factor receptor 2 negative breast cancer. MEI Pharma, Inc. has a license agreement with Presage Biosciences, Inc. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.

Today's Range

Now: $3.07

$3.00

$3.10

50 Day Range

MA: $2.93

$2.67

$3.18

52 Week Range

Now: $3.07

$2.61

$7.87

Volume

14,252 shs

Average Volume

52,363 shs

Market Capitalization

$20.45 million

P/E Ratio

1.15

Dividend Yield

N/A

Beta

0.85

Who are the company insiders with the largest holdings of MEI Pharma?: MEI Pharma's top insider shareholders include:
Anson Funds Management Lp (Major Shareholder)
Charles V Baltic III (Director)
Learn More about top insider investors at MEI Pharma.